MIR Earnings

MIR reported its earnings on 2026-02-10, showcasing a revenue of 277.40M against an estimate of 281.82M, resulting in a -1.57% surprise. The EPS was 0.14, surpassing the expected 0.15 by -6.67%. The stock experienced a -10.2% price change on the earnings day and a -6.19% change over the next five days, reflecting market reactions to the results.

Following MIR's earnings announcement on 2026-02-10, the stock price moved by -10.2% on the day of the release. Over the subsequent five days, it saw a -6.19% change. Historically, MIR's stock price tends to shift by an average of -2.4% in the 10 days leading up to earnings and -0.39% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate MIR's annual revenue to reach 247.60M, while the EPS is projected at 0.13. These estimates reflect recent revisions, with revenue estimates revised upward by 0.22% and EPS estimates revised upward by 0.72% over the past three months, indicating analyst expectation in the company's performance.

The correlation between MIR's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were revised upward by 0.22%, while EPS estimates moved revised upward by 0.72%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, MIR's stock price typically moves by -2.4% in the 10 days before its earnings and -0.39% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.13 and revenue of 247.60M.

The earnings call highlighted strong financial metrics, optimistic guidance, and strategic acquisitions, particularly in the nuclear sector. The company's focus on AI and digital strategies, along with a positive outlook for 2025 and beyond, supports a positive sentiment. While some uncertainties remain, such as specific win rates and AI KPIs, the overall narrative is growth-oriented, with significant opportunities in nuclear power and medicine. Given the mid-cap status, the market is likely to react positively, but not excessively, resulting in a positive prediction of 2% to 8% stock price increase.